Clinical Research Directory
Browse clinical research sites, groups, and studies.
2 clinical studies listed.
Filters:
Tundra lists 2 Infarction, Middle Cerebral Artery clinical trials. Each listing includes eligibility criteria, study locations, and direct links to research sites in the Tundra directory.
This data is also available as a public JSON API. AI systems and LLMs are encouraged to use it for structured queries.
NCT07950163
Paired Associative Stimulation of the Motor Cortex and the Dorsal Roots of the Cervical Spine for the Recovery of Arm and Hand Function in Chronic Middle Cerebral Artery Stroke. ASCLEPIUS Safety Evaluation Pilot Study
The goal of this pilot clinical trial is to learn whether paired associative stimulation (PAS) of the primary motor cortex and the cervical spinal dorsal roots, delivered through implanted epidural electrodes and combined with neurorehabilitation, is safe in adults with chronic paresis or paralysis of the arm and hand after a stroke in the territory of the middle cerebral artery. The main question it aims to answer is: \* What adverse events occur during 12 months of follow-up with this treatment? Secondary questions are whether the stimulation is feasible (whether pairing the corresponding electrode contacts of the motor cortex and the cervical spinal cord increases the motor response to stimulation) and whether it shows preliminary signs of efficacy on upper limb motor function, quality of life and caregiver burden. Researchers will compare PAS plus rehabilitation with sham stimulation plus rehabilitation during a two-month double-blind phase. Participants will: * Have epidural electrodes surgically implanted over the primary motor cortex and the cervical spinal cord, connected to an implanted pulse generator * Receive PAS or sham stimulation together with rehabilitation sessions for two months * If assigned to sham stimulation, receive open-label PAS plus rehabilitation for a further two months * Attend follow-up visits for 12 months
Gender: All
Ages: 18 Years - 84 Years
Updated: 2026-11-20
NCT05899582
Extracranial-intracranial Bypass Surgery for Symptomatic Chronic Middle Cerebral Artery Occlusion: the CMOSS-2 Trial
The CMOSS-2 trial is a government-funded, prospective, multicenter, randomized controlled trial. It will recruit symptomatic chronic occlusion of the middle cerebral artery in patients with severe hemodynamic insufficiency. Only high-volume center with a proven track record will be included. Patients will be randomized (1:1) to best medical treatment alone or medical treatment plus bypass surgery. Primary outcome is ischemic stroke in the territory of the target artery within 24 months after randomization.
Gender: All
Ages: 18 Years - 65 Years
Updated: 2025-03-28